fda semaglutide update says that the GLP-1 shortage is over fda semaglutide shortage status january

That new pathway needs its own adjustment period

Discussion This study adds to the limited available data on the use of semaglutide in patients with advanced CKD and provides insight over a prolonged follow-up period exceeding three years (median 1,187 days [IQR 6021,442]), with the majority of patients receiving maintenance hemodialysis (58.8%)

Without adequate bulk, stool can sit in the colon for days, leading to the hard, dry, difficult-to-pass bowel movements that many semaglutide users report

Improvements in Heart Health Early data suggests lower blood pressure, reduced cholesterol, and potential cardiovascular benefits similar to other GLP-1 drugs

Flare frequency decreases

Working with a registered dietitian experienced in IBD can help develop a nutritionally adequate, calorie-controlled eating plan that avoids triggering UC symptoms